Literature DB >> 7641827

Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.

N J Gay1, L M Hesketh, P Morgan-Capner, E Miller.   

Abstract

Serological surveillance of measles immunity has been carried out in England since 1986/7. Results from sera collected in 1989-91 revealed that the proportion of school age children who were susceptible to measles was increasing, following the introduction of the measles, mumps and rubella vaccination programme in October 1988. Mathematical models are used to interpret these data and determine whether this increasing susceptibility is sufficient to allow a resurgence of disease from the low levels achieved by 1993. The models summarize serological profiles by a single parameter, the reproduction number R, which quantifies the level of herd immunity in the population. Results showed that there was cause for concern over the levels of susceptibility to measles, with an epidemic of over 100,000 cases likely in 1995/6. These predictions are consistent with trends in the incidence and age distribution of measles and have enabled the planning of a major vaccination campaign.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641827      PMCID: PMC2271572          DOI: 10.1017/s0950268800058209

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations.

Authors:  O Diekmann; J A Heesterbeek; J A Metz
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

3.  Surveillance of antibody to measles, mumps, and rubella by age.

Authors:  P Morgan-Capner; J Wright; C L Miller; E Miller
Journal:  BMJ       Date:  1988-09-24

4.  Outbreaks in highly vaccinated populations: implications for studies of vaccine performance.

Authors:  P E Fine; E R Zell
Journal:  Am J Epidemiol       Date:  1994-01-01       Impact factor: 4.897

5.  The impact of college prematriculation immunization requirements on risk for measles outbreaks.

Authors:  A L Baughman; W W Williams; W L Atkinson; L G Cook; M Collins
Journal:  JAMA       Date:  1994-10-12       Impact factor: 56.272

6.  The new measles campaign.

Authors:  E Miller
Journal:  BMJ       Date:  1994-10-29

7.  Modelling forces of infection for measles, mumps and rubella.

Authors:  C P Farrington
Journal:  Stat Med       Date:  1990-08       Impact factor: 2.373

8.  Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.

Authors:  R M Anderson; R M May
Journal:  J Hyg (Lond)       Date:  1985-06

9.  Outbreak of measles in a teenage school population: the need to immunize susceptible adolescents.

Authors:  D Morse; M O'Shea; G Hamilton; N Soltanpoor; G Leece; E Miller; D Brown
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

10.  Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.

Authors:  R M Anderson; B T Grenfell
Journal:  J Hyg (Lond)       Date:  1986-04
View more
  31 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

2.  Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.

Authors:  David A Ishola; Ray Borrow; Helen Findlow; Jamie Findlow; Caroline Trotter; Mary E Ramsay
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

3.  Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

Authors:  Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

Review 4.  Should measles be eradicated?

Authors:  F T Cutts; R Steinglass
Journal:  BMJ       Date:  1998-03-07

5.  Immunisation policies--successes, failures and the future.

Authors:  E Miller
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

6.  Age-structure and transient dynamics in epidemiological systems.

Authors:  F M G Magpantay; A A King; P Rohani
Journal:  J R Soc Interface       Date:  2019-07-31       Impact factor: 4.118

7.  Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.

Authors:  M Petrovic; R Roberts; M Ramsay
Journal:  BMJ       Date:  2001-01-13

8.  Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.

Authors:  Todd F Hatchette; Heidi Scholz; Shelly Bolotin; Natasha S Crowcroft; Colleen Jackson; Elizabeth McLachlan; Alberto Severini
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

9.  Measles immunity and response to revaccination among secondary school children in Cumbria.

Authors:  N Calvert; F Cutts; R Irving; D Brown; J Marsh; E Miller
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

Review 10.  One model to rule them all? Modelling approaches across OneHealth for human, animal and plant epidemics.

Authors:  Adam Kleczkowski; Andy Hoyle; Paul McMenemy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-06-24       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.